#

Small caps

: 1296
A group of investors led by billionaire Nelson Peltz’s fund wants to buy burger chain Wendy’s / Photo: Shutterstock.com
Small Caps·
Small caps last week: Battle for Wendy’s, Brazil selloff, Innodata layoffs
Build-A-Bear shares have lost half their value over the last 12 months / Photo: Shutterstock.com
Small Caps·
Burry sees value in Build-A-Bear shares as the business faces more tough quarters
Aspen Neuroscience shares will trade on the Nasdaq under the ticker symbol ASPE / Photo: Unsplash / Vitaly Gariev
Small Caps·
Aspen IPO: Altman-backed, Parkinson’s-focused biotech debuts on the Nasdaq
Bambusa Therapeutics raised $168.9 million in its Nasdaq IPO / Photo: Unsplash / CDC
Small Caps·
Bambusa IPO: Dermatology biotech to debut on the Nasdaq
Ultralife manufactures non-rechargeable and rechargeable batteries and communications equipment / Photo: www.ultralifecorporation.com
Small Caps·
Battery maker Ultralife soars 145% on takeover by rival EnerSys
The summer months saw small-cap returns cool while mega-caps and other large, mostly AI-centric names rebounded / Photo: Shutterstock.com
Small Caps·
The small-cap rally stalled in the 3Q. Which ETFs stayed above water for 9m26?
Media reports describe layoffs at Innodata in India and the Philippines / Photo: Facebook / Innodata.Inc
Small Caps·
AI data firm Innodata sinks on mass layoffs amid reduced work for major client
Analysts forecast annual earnings growth of more than 10% over the next five years for PagSeguro, which operates under the PagBank brand / Photo: Facebook / pagbank
Small Caps·
‘Investors are upset’: Brazilian fintech PagSeguro plunges amid election surprise
Groupe SEB shares have gained around 8% year to date / Photo: Groupeseb.com
Small Caps·
Tefal owner SEB is restoring profitability. What does that mean for the stock?
Aardvark plans to agree on a new phase III trial design with the FDA and resume clinical development of ARD-101 next year / Photo: Unsplash / Julia Koblitz
Small Caps·
Aardvark sinks 65% on data from halted trial of hunger drug; FDA to allow new tests
Robert Half is seeing increased demand for compliance work following Treasury Department enforcement actions / Photo: Facebook / roberthalf
Small Caps·
Staffing company Robert Half soars as Wall Street bets on a 'strong comeback'
Merck will acquire Silence Therapeutics, which is developing a treatment for a rare blood cancer / Photo: www.silence-therapeutics.com
Small Caps·
Small caps last week: Deals for Silence and Braze, hair-loss pill success
Load more